DeepMed Research

UNIVERSITY OF MINNESOTA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1851-01-01

Employees: 10K

Market Cap: -

Website: http://www.umn.edu

Clinical Trials

Intraoperative Sublingual Sufentanil for Acute Pain in the Ambulatory Surgery Center

Phase 4

Completed

Conditions: Anesthesia
Pain
Pain, Acute

Interventions: Drug: Sublingual Sufentanil

First Posted Date: 2020-05-13

Last Posted Date: 2022-06-28

Lead Sponsor: University of Minnesota

Target Recruit Count: 53

Registration Number: NCT04387136

Locations: 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States

Recurrent Hypoglycemia in Type 1 Diabetes (Aim 2)

Not Applicable

Active, not recruiting

Conditions: Diabetes Mellitus, Type 1

Interventions: Other: Experimental hyperglycemia

First Posted Date: 2020-05-13

Last Posted Date: 2025-04-17

Lead Sponsor: University of Minnesota

Target Recruit Count: 50

Registration Number: NCT04387422

Locations: 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States

International SARS-CoV-2 (COVID-19) Infection Observational Study

Completed

Conditions: SARS-CoV 2
Dyspnea
COVID19
COVID

Interventions: Other: Data Collection

First Posted Date: 2020-05-12

Last Posted Date: 2022-08-16

Lead Sponsor: University of Minnesota

Target Recruit Count: 11973

Registration Number: NCT04385251

Locations: 🇦🇷
Hospital General de Agudos JM Ramos Mejia Servicio de Inmunocomprometidos, Buenos Aires, Argentina
🇺🇸
Denver Public Health, Denver, Colorado, United States
🇬🇧
University College London Medical School Centre for Sexual Health and HIV Research, London, England, United Kingdom

and more 1 locations

Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS): Clinical Characterization and Prospective Course

Completed

Conditions: PANDAS
PANS

Interventions: Other: No intervention

First Posted Date: 2020-05-11

Last Posted Date: 2020-05-11

Lead Sponsor: University of Minnesota

Target Recruit Count: 22

Registration Number: NCT04382716

Locations: 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States

Brivaracetam to Reduce Neuropathic Pain in Chronic Spinal Cord Injury

Phase 1

Completed

Conditions: Spinal Cord Injuries

Interventions: Drug: Brivaracetam
Other: Placebo

First Posted Date: 2020-05-07

Last Posted Date: 2025-04-27

Lead Sponsor: University of Minnesota

Target Recruit Count: 24

Registration Number: NCT04379011

Locations: 🇺🇸
University of Minnesota School of Medicine, Minneapolis, Minnesota, United States
🇺🇸
Swedish Hospital, Englewood, Colorado, United States

Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS)

Completed

Conditions: Coronavirus Infection
Covid-19
COVID
SARS-CoV-2

Interventions: Diagnostic Test: Point-of-Care Ultrasonography (POCUS)

First Posted Date: 2020-04-09

Last Posted Date: 2023-01-04

Lead Sponsor: University of Minnesota

Target Recruit Count: 129

Registration Number: NCT04339998

Locations: 🇺🇸
University of Minnesota Medical Center (UMMC), Minneapolis, Minnesota, United States
🇺🇸
M Health Fairview Bethesda Hospital, Saint Paul, Minnesota, United States

Pre-exposure Prophylaxis for SARS-Coronavirus-2

Phase 3

Completed

Conditions: Corona Virus Infection
Acute Respiratory Distress Syndrome
COVID-19
ARDS

Interventions: Other: Placebo
Drug: Hydroxychloroquine

First Posted Date: 2020-03-31

Last Posted Date: 2021-07-02

Lead Sponsor: University of Minnesota

Target Recruit Count: 1483

Registration Number: NCT04328467

Locations: 🇺🇸
Nationwide Enrollment via Internet, please email: covid19@umn.edu, Minneapolis, Minnesota, United States
🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States

Treatment of Chronic Itch in Atopic Dermatitis With Opioid Antagonist Naltrexone

Phase 2

Withdrawn

Conditions: Pruritus
Atopic Dermatitis
Dermatitis
Pruritus Chronic

Interventions: Drug: Naltrexone
Other: Placebo

First Posted Date: 2020-03-30

Last Posted Date: 2023-04-04

Lead Sponsor: University of Minnesota

Registration Number: NCT04325802

Locations: 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States

Systemic Markers of Inflammation: 9- and 12-Month Follow-Up Post Non-Surgical Periodontal Therapy

Completed

Conditions: Minocycline HCl Microspheres
SRP
Biomarkers

Interventions: Procedure: Measurement of Biomarkers

First Posted Date: 2020-03-18

Last Posted Date: 2022-09-23

Lead Sponsor: University of Minnesota

Target Recruit Count: 60

Registration Number: NCT04312542

Locations: 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States

Social Buffering During Aversive Conditioning

Not Applicable

Recruiting

Conditions: Social Stress
Adolescent Behavior

Interventions: Other: Questionnaires
Other: MRI

First Posted Date: 2020-03-18

Last Posted Date: 2025-05-15

Lead Sponsor: University of Minnesota

Target Recruit Count: 200

Registration Number: NCT04312945

Locations: 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy